Cambridge Investment Research Advisors’s Calamos Nasdaq-100 Structured Alt Protection ETF - December CPNQ Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CPNQ Stock Details CPNQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-51,068	Closed	-$1.36M	–	4167
2026 Q1	$1.36M	Sell	51,068 -3,591	-7%	-$95.4K	﹤0.01%	1913
2025 Q4	$1.45M	Buy	+54,659	New	+$1.44M	﹤0.01%	1802

Other funds holding CPNQ

Leelyn Smith Geneva, Illinois $822M AUM 31.69% 1-Year Est. Return

CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return

Cambridge Investment Research Advisors's CPNQ Position: Q2 2026 in Review

Cambridge Investment Research Advisors sold out of Calamos Nasdaq-100 Structured Alt Protection ETF - December (CPNQ) in Q2 2026, closing a stake of 51,068 shares — an estimated $1.36M sold.

Cambridge Investment Research Advisors first reported a position in CPNQ in Q4 2025 and held it in 2 quarters. The position peaked at $1.45M in Q4 2025. 2 funds tracked by Wall St. Rank hold CPNQ as of Q2 2026.

Cambridge Investment Research Advisors reported no remaining Calamos Nasdaq-100 Structured Alt Protection ETF - December position as of Q2 2026 after selling out during the quarter.
Cambridge Investment Research Advisors sold 51,068 Calamos Nasdaq-100 Structured Alt Protection ETF - December shares in Q2 2026, an estimated $1.36M.
Cambridge Investment Research Advisors first reported a position in Calamos Nasdaq-100 Structured Alt Protection ETF - December in Q4 2025 and held it in 2 quarters.
Cambridge Investment Research Advisors's Calamos Nasdaq-100 Structured Alt Protection ETF - December position peaked at $1.45M in Q4 2025.
2 funds tracked by Wall St. Rank held Calamos Nasdaq-100 Structured Alt Protection ETF - December as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.